Chemotherapy Agents: Platar - Aroplatin
JLIKE
o aroplatin.htm
§ Aronex Pharmaceuticals Receives Orphan Drug Designation for Mesothelioma Indication for Platar (now "Aroplatin") (11/10/99)
o perez-s.htm
§ Letter from Dr. Roman Perez-Solar Regarding L-NNDP, (6/30/99)
o platar.htm
§ Phase II Trial using Platar Shows Promise; MD Anderson Hospital, Houston, TX; Kaplan Cancer Center, NYC, (5/17/99)
o l-nddp1.htm
§ Phase I Study of Platar on Peritoneal Mesothelioma, M.D. Anderson, (5/99)
· oxaliplatin.htm
o Oxaliplatin Plus Raltitrexed Active in Mesothelioma (7/16/03)
· sequential_chemo.htm
o Sequential Chemotherapy for Pleural Mesothelioma Promising (4/12/06)
· early_chemo.htm
o Early Chemotherapy Improves Outcomes for Mesothelioma (2/9/06)
· MORAb_jan03.htm
o Morphotek Expands Oncology Pipeline With Product Candidate (MORAb-009) From the National Cancer Institute (NCI) (01/05/06)
· cisplatin_pemetrexed.htm
o Unresectable Mesothelioma: A New Standard of Care (5/29/02)
· chicago.htm
o Overview of Current Therapies for Mesothelioma, including Alimta, Doxorubicin, Methotrexate, Gemzar and other Agents. Malignant Mesothelioma -- Therapeutic Options and Role of SV40, Univ. Of Chicago, April 20, 2001 (4/27/01) [Alimta]
· onconas7.htm
o Mesothelioma: Insights and Observations (10/2/00)
· articles2.htm
o Summary of Medical Articles Concerning Treatment Options for Mesothelioma Patients. Source - MEDLINE
o A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma (10/14/02)
· vinorelbine.htm
o Phase II Study of Vinorelbine in Patients With Malignant Pleural Mesothelioma Shows Improvement in Survival and Quality of Life (12/8/00 )
· gemcitabine.htm
o A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies (response noted for Mesothelioma Patient). (3/27/00)
· immunoch.htm
o Successful Immunochemotherapy for Patients with MM: M. Tani, 1998
· passart.htm
o "Immunochemotherapy for Mesothelioma," Dr. Harvey Pass, 1995
· doxoru.htm
o Peptide-Doxorubicin a Potent Anti-Tumor Cocktail in Mice, La Jolla, Jan. 19, 1998
· irinotec.htm
o A Pilot Phase II Study of Irinotecan (CPT-11) in Combintation with Cisplatin Administered Instravenously to Patients with Malignant Mesothelioma.
· tlk286.htm
o TLK286 Phase 1 Results At American Society of Clinical Oncology Meeting (6/29/01)